Israel has reached an agreement to receive 10 million doses of the Oxford University Covid-19 vaccine.
The news was announced in a joint statement by the Israeli government and pharmaceutical company AstraZeneca, which is manufacturing the vaccine.
Subject to approval by the regulatory authorities, an initial supply is expected to arrive in Israel in the first half of 2021. With two doses required per person, the supply would cover at least half the Israeli population.
Israel has signed supply arrangements for the Pfizer and Moderna vaccines, and is reportedly in talks with Russia for its Sputnik V vaccine. But the AstraZeneca deal is its biggest – and the latest data suggests a strong immune response in older adults.
